The Organisation of Pharmaceutical Producers of India (OPPI) has appointed GlaxosmithKilne Pharmaceuticals Managing Director Bhushan Akshikar as its President, for two years from September 26, 2024.
Bhushan has over 13 years experience in key leadership roles in GSK across India, Middle East, Russia CIS & Africa region. And before GSK, Bhushan spent 15 years with Janssen, Johnson & Johnson, in local and regional positions in India, South Korea and Belgium, the OPPI said. He takes over from Suresh Pattathil, Managing Director and General Manager, AbbVie.
On the new assignment, Bhushan said, over the years, OPPI’s focus has been on collective action to forge a path towards a more inclusive, innovative, and sustainable healthcare future for the country. The OPPI, established in 1965, is a platform for global pharmaceutical companies in India.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.